Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Type of study
Publication year range
1.
Biol Pharm Bull ; 44(12): 1851-1859, 2021.
Article in English | MEDLINE | ID: mdl-34853267

ABSTRACT

The physical characteristics and behavior of the ATP-binding cassette (ABC) A1, A7, and apolipoprotein (apo) E knockout (KO) mice with lipid transport dysfunction were investigated. These KO mice exhibited adequate growth, and their body masses increased steadily. No remarkable changes were observed in their blood pressure and heart rate. However, there was a slight increase in the heart rate of the ABCA7 KO mice compared with that of the wild-type (WT) mice. ABCA1 and apoE KO mice showed hypo- and hyper-cholesterol concentrations in the plasma, respectively. With regard to the cerebrum, however, the weight of the ABCA1 KO mice was lighter than those of the other genotypes. Furthermore, the cholesterol, triglyceride and phospholipid concentrations, and fatty acid composition were generally similar. Compared with the WT mice, ABCA1 KO mice stayed for a shorter time in the closed arm of the elevated plus maze, and performed worse in the initial stage of the Morris water maze. To thermal stimuli, the ABCA1 and apoE KO mice showed hyper- and hypo-sensitivities, respectively. Only the response of the ABCA1 KO mice was significantly inhibited by pretreatment with indomethacin. A low concentration of the prostaglandin E metabolites was detected in the plasma of the ABCA1 KO mice. Thus, ABCA1 is thought to play a specific role in the neural function.


Subject(s)
ATP Binding Cassette Transporter 1/metabolism , ATP-Binding Cassette Transporters/metabolism , Apolipoproteins E/metabolism , Brain/metabolism , Dyslipidemias/metabolism , Lipids/blood , Alzheimer Disease/metabolism , Animals , Atherosclerosis/metabolism , Behavior, Animal , Biological Transport , Cholesterol/blood , Cognition , Fatty Acids/blood , Hyperalgesia/metabolism , Lipid Metabolism , Locomotion , Male , Maze Learning , Mice, Knockout , Phospholipids/blood , Prostaglandins E/blood , Triglycerides/blood
2.
J Pharmacol Sci ; 144(2): 61-68, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32684333

ABSTRACT

The effects of adipokine administration to the hypothalamic preoptic area (POA), which is one of the body temperature (BT) regulation centers in the central nervous system, on BT were investigated in male Wistar rats. BT was measured in conscious rats using telemetry. Insulin-like growth factor-1 (IGF-1), interleukin-1ß (IL-1ß), monocyte chemoattractant protein-1 and lipocalin-2 produced hyperthermia, and the effects induced by IL-1ß (25 ng) and IGF-1 (5 µg) were sustainable and remarkable. IL-6 did not show any significant effect. The IGF-1-induced effect was inhibited by pretreatment with IGF binding protein 3 (IGFBP3) or NVP-AEW541 (NVP, a selective inhibitor of type 1 IGF receptor tyrosine kinase, IGF1R TK). NVP-induced inhibition was observed only in the early phase of IGF-1-induced hyperthermia. In addition, IGF-1 increased the IL-1ß concentration in the microdialysate of POA perfusion, but did not increase the IL-1ß concentration in the plasma or the PGE2 concentration in the microdialysate. These findings suggested that IGF-1 produced hyperthermia, which was mediated, at least a part, through an increased IL-1ß concentration after activation of IGF1R TK in the POA, and the IGF-IGFBP system possibly participates in BT homeostasis in the POA.


Subject(s)
Adipokines/administration & dosage , Adipokines/pharmacology , Body Temperature/drug effects , Body Temperature/genetics , Preoptic Area/metabolism , Preoptic Area/physiology , Animals , Chemokine CCL2/administration & dosage , Chemokine CCL2/pharmacology , Fever/chemically induced , Fever/genetics , Insulin-Like Growth Factor I/administration & dosage , Insulin-Like Growth Factor I/pharmacology , Interleukin-1beta/administration & dosage , Interleukin-1beta/metabolism , Interleukin-1beta/pharmacology , Lipocalin-2/administration & dosage , Lipocalin-2/pharmacology , Male , Protein-Tyrosine Kinases/metabolism , Rats, Wistar , Receptor, IGF Type 1/metabolism
3.
Biol Pharm Bull ; 42(11): 1877-1882, 2019.
Article in English | MEDLINE | ID: mdl-31685769

ABSTRACT

Intracerebroventricular (icv) injection of transient receptor potential vanilloid 4 (TRPV4) agonists 4α-phorbol-12, 13-didecanoate (4α-PDD) and GSK101690A increased urinary excretion under the physiological condition. TRPV4 antagonists ruthenium red and HC-067047 significantly blocked increased urinary volume after intragastric administration of water and 4α-PDD-induced diuresis. Administration of the TRPV4 agonists did not significantly change the plasma concentration of vasopressin or atrial natriuretic factor. Pretreatment with indomethacin inhibited the diuresis induced by 4α-PDD. Moreover, icv injection of prostaglandin (PG) F2α produced diuretic effects. These findings indicate that central TRPV4 regulates urine excretion, which contributes to systemic water homeostasis in vivo. The underlying mechanisms are suggested to involve PG synthesis, but not release of vasopressin or atrial natriuretic factor.


Subject(s)
Diuresis/drug effects , Drinking/drug effects , Homeostasis/drug effects , Phorbol Esters/pharmacology , TRPV Cation Channels/agonists , Urination/drug effects , Animals , Atrial Natriuretic Factor/blood , Dinoprost/pharmacology , Indomethacin/pharmacology , Male , Morpholines/pharmacology , Pyrroles/pharmacology , Rats , Rats, Wistar , Ruthenium Red/pharmacology , Vasopressins/blood
4.
Biol Pharm Bull ; 37(6): 1003-13, 2014.
Article in English | MEDLINE | ID: mdl-24882411

ABSTRACT

We investigated whether body temperature (BT) regulatory mechanisms are influenced by dietary fatty acids (FA). Male Wistar rats were fed a high-fat diet containing fish oil (HFD), soybean oil (HSD) or lard (HLD). At the 20-week intervention, the BT of the HSD and HLD groups were lower than that of the normal diet (ND) group in the light and dark periods. The intracerebroventricular injections of interleukin-1ß and bombesin in the HSD group induced greater hyperthermia and weaker hypothermia, respectively, than in the ND group. The HSD differentially affected BT under both physiological and pharmacological conditions. In the hypothalamus, the ratio of n-6/n-3 FAs was higher in the HSD group compared with the ND group. DNA microarrays revealed increased expression of thyroid-stimulating hormone ß-subunit, and decreased expression of several genes in the hypothalamus of the HSD group compared with the ND group. The HSD feeding increased several adipokine concentrations in the plasma. However, there were no adipokines or gene expressions that changed in only the HSD and HLD groups showing significant hypothermia under the physiological condition. These findings suggested that long-term HSD intake produces abnormal BT regulation. It is less likely that adipokines or proteins/peptides are involved in abnormal BT regulation under the physiological conditions after HSD feeding.


Subject(s)
Body Temperature Regulation/drug effects , Diet, High-Fat , Soybean Oil/pharmacology , Adipokines/blood , Animals , Body Temperature/drug effects , Body Temperature Regulation/genetics , Body Weight/drug effects , Bombesin/pharmacology , Dietary Fats/administration & dosage , Dietary Fats/pharmacology , Energy Metabolism/drug effects , Fatty Acids/blood , Fatty Acids/metabolism , Fish Oils/administration & dosage , Fish Oils/pharmacology , Gene Expression/drug effects , Hypothalamus/drug effects , Hypothalamus/metabolism , Interleukin-1beta/pharmacology , Male , Motor Activity/drug effects , Photoperiod , Rats, Wistar , Soybean Oil/administration & dosage , Time Factors
5.
Lipids ; 48(8): 803-15, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23807365

ABSTRACT

Epidemiologic and ecologic studies suggest that dietary fat plays an important role in the development of obesity. Certain Wistar rat strains do not become obese when fed high-fat diets unlike others. In a preliminary study, we confirmed that Slc:Wistar/ST rats did not become obese when fed high-fat diets. The mechanisms governing the response of hepatic lipid-metabolizing enzymes to large quantities of dietary lipids consumed by obesity-resistant animals are unknown. The aim of the present study is to examine how obesity-resistant animals metabolize various types of high-fat diets and why they do not become obese. For this purpose, male Slc:Wistar/ST rats were fed a control low-fat diet (LS) or a high-fat diet containing fish oil (HF), soybean oil (HS), or lard (HL) for 4 weeks. We observed their phenotypes and determined lipid profiles in plasma and liver as well as mRNA expression levels in liver of genes related to lipid and glucose metabolism using DNA microarray and quantitative reverse transcriptase polymerase chain analyses. The body weights of all dietary groups were similar due to isocaloric intakes, whereas the weight of white adipose tissues in the LS group was significantly lower. The HF diet lowered plasma lipid levels by accelerated lipolysis in the peroxisomes and suppressed levels of very-low-density lipoprotein (VLDL) secretion. The HS diet promoted hepatic lipid accumulation by suppressed lipolysis in the peroxisomes and normal levels of VLDL secretion. The lipid profiles of rats fed the LS or HL diet were similar. The HL diet accelerated lipid and glucose metabolism.


Subject(s)
Diet, High-Fat/adverse effects , Glucose/metabolism , Lipid Metabolism/drug effects , Adipose Tissue, White/drug effects , Animals , Body Weight/drug effects , Dietary Fats/analysis , Dietary Fats/metabolism , Dietary Fats/pharmacokinetics , Dietary Fats/pharmacology , Eating/drug effects , Energy Intake/drug effects , Fatty Acids/analysis , Fatty Acids/chemistry , Fish Oils/analysis , Fish Oils/pharmacology , Gene Expression Regulation/drug effects , Lipid Metabolism/genetics , Lipoproteins, VLDL/metabolism , Liver/drug effects , Liver/metabolism , Liver/physiology , Male , Obesity/metabolism , Rats , Rats, Wistar , Soybean Oil/analysis , Soybean Oil/pharmacology
6.
J Atheroscler Thromb ; 16(6): 722-32, 2009.
Article in English | MEDLINE | ID: mdl-19755789

ABSTRACT

AIM: Atherosclerosis is a cardiovascular disease; however, there is little information on signal transduction for vascular function in the early stage of atherosclerosis. In this work, we investigated the role of Rho/Rho-kinase and nitrogen oxide (NO)/cyclic GMP (cGMP) signaling pathways in the aorta prior to atherosclerosis. METHODS: Tension, the expression of RhoA protein, Rho-kinase activity and the cGMP level were measured using endothelium-intact or -denuded aorta prepared from apolipoprotein E-deficient (apoE-KO) and C57BL/6 wild-type (WT) mice at 2 months of age. RESULTS: Phenylephrine (PE) induced less maximal contraction in the endothelium-denuded aorta from apoE-KO than from WT mice. A Rho-kinase inhibitor (Y-27632) reduced more effectively the contraction of apoE-KO than WT mice, but their RhoA proteins and Rho-kinase activities were not so different. Acetylcholine caused larger relaxation of the PE-stimulated, endothelium-intact aorta in apoE-KO due to endothelial NO release than WT mice. The basal cGMP level in the endothelium-intact aorta of apoE-KO mice was higher than that of WT. CONCLUSIONS: Smooth muscle contraction via alpha(1)-adrenergic receptor shows higher dependency on Rho-kinase activity, suggesting down-regulation of the mechanism different from Rho/Rho kinase signaling in the aorta prior to atherosclerosis. Endothelium-dependent relaxation is also intensified through the NO/cGMP pathway.


Subject(s)
Atherosclerosis/enzymology , Atherosclerosis/metabolism , Nitric Oxide/metabolism , Signal Transduction , rho GTP-Binding Proteins/metabolism , rho-Associated Kinases/metabolism , Amides/pharmacology , Animals , Apolipoproteins E/genetics , Atherosclerosis/pathology , Cyclic GMP/metabolism , Endothelium, Vascular/pathology , Humans , Mice , Mice, Inbred C57BL , Mice, Knockout , Muscle Contraction , Pyridines/pharmacology
7.
Am J Physiol Regul Integr Comp Physiol ; 290(6): R1736-41, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16439673

ABSTRACT

Transient receptor potential vanilloid 4 (TRPV4) is one member of the TRP superfamily of nonselective cation channels. Recently, the possibility has been raised that TRPV4 is an osmoreceptor, because it is found in the circumventricular organs where osmoreceptors are supposed to be distributed and because it is sensitive to osmotic pressure in in vitro experiments. In addition, TRPV4 knockout mice have abnormal osmosensitivity. In this study, effects of 4alpha-phorbol 12,13-didecanoate (4alpha-PDD), a TRPV4 agonist, on drinking behavior were examined to investigate roles for TRPV4 as an osmoreceptor in vivo in wild-type animals. Intracerebroventricular injections of 4alpha-PDD inhibited water intake under normal conditions in both light and dark periods of the day, after food deprivation, and after administration of angiotensin II. However, this drug did not influence increased water intake after administration of a hypertonic solution or after water deprivation that significantly increased plasma osmolality. Locomotor activity of the 4alpha-PDD-injected group decreased slightly compared with that of the vehicle-injected group; however, sweet taste, food intake, and body temperature were not different between the two groups. The antidipsogenic effects of 4alpha-PDD were blocked by preinjection into the ventricle of TRPV4 antagonists such as ruthenium red or gadolinium. These findings suggest that TRPV4 regulates drinking behavior under certain conditions, and the regulation interacts with the angiotensin II pathway.


Subject(s)
Phorbol Esters/pharmacology , TRPV Cation Channels/agonists , Thirst/drug effects , Angiotensin II/pharmacology , Animals , Body Temperature/drug effects , Dose-Response Relationship, Drug , Drinking/drug effects , Drinking Behavior/drug effects , Eating/drug effects , Food Deprivation , Gadolinium/pharmacology , Injections, Intraventricular , Male , Motor Activity/drug effects , Phorbol Esters/administration & dosage , Photoperiod , Rats , Rats, Wistar , Ruthenium Red/pharmacology , TRPV Cation Channels/antagonists & inhibitors , TRPV Cation Channels/physiology , Water Deprivation , Water-Electrolyte Balance/drug effects , Water-Electrolyte Balance/physiology
8.
Eur J Pharmacol ; 530(1-2): 144-51, 2006 Jan 13.
Article in English | MEDLINE | ID: mdl-16360146

ABSTRACT

The mechanisms underlying transient receptor potential vanilloid receptor type 1 (TRPV1)-independent relaxation elicited by capsaicin were studied by measuring isometric force and phosphorylation of 20-kDa regulatory light chain subunit of myosin (MLC(20)) in ileum longitudinal smooth muscles of guinea-pigs. In acetylcholine-stimulated tissues, capsaicin (1-100 microM) and resiniferatoxin (10 nM-1 microM) produced a concentration-dependent relaxation. The relaxant response was attenuated by 4-aminopyridine and high-KCl solution, but not by capsazepine, tetraethylammonium, Ba(2+), glibenclamide, charybdotoxin plus apamin nor antagonists of cannabinoid receptor type 1 and calcitonin-gene related peptide. A RhoA kinase inhibitor reduced the relaxant effect of capsaicin at 30 microM. Capsaicin and resiniferatoxin reduced acetylcholine- and caffeine-induced transient contractions in a Ca(2+)-free, EGTA solution. Capsaicin at 30 microM for 20 min did not alter basal levels of MLC(20) phosphorylation, but abolished an increase by acetylcholine in MLC(20) phosphorylation. It is suggested that the relaxant effect of capsaicin at concentrations used is not mediated by TRPV1, but by 4-aminopyridine-sensitive K(+) channels, and that capsaicin inhibits contractile mechanisms involving Ca(2+) release from intracellular storage sites. The relaxation could be explained by a decrease in phosphorylation of MLC(20).


Subject(s)
Capsaicin/analogs & derivatives , Capsaicin/pharmacology , Ileum/drug effects , Muscle Relaxation/drug effects , 4-Aminopyridine/pharmacology , Acetylcholine/pharmacology , Animals , Apamin/pharmacology , Barium/pharmacology , Benzopyrans/pharmacology , Caffeine/pharmacology , Calcitonin Gene-Related Peptide/pharmacology , Calcium/metabolism , Capsaicin/antagonists & inhibitors , Charybdotoxin/pharmacology , Diclofenac/pharmacology , Dimethyl Sulfoxide/pharmacology , Diterpenes/pharmacology , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Glyburide/pharmacology , Guanethidine/pharmacology , Guinea Pigs , Ileum/physiology , In Vitro Techniques , Intracellular Signaling Peptides and Proteins , Male , Muscle, Smooth/drug effects , Muscle, Smooth/physiology , Myosin Light Chains/metabolism , Nitroarginine/pharmacology , Papaverine/pharmacology , Peptide Fragments/pharmacology , Phosphodiesterase Inhibitors/pharmacology , Phosphorylation/drug effects , Piperidines/pharmacology , Potassium Channel Blockers/pharmacology , Potassium Channels/physiology , Potassium Chloride/pharmacology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Pyrazoles/pharmacology , Receptor, Cannabinoid, CB1/antagonists & inhibitors , Tetraethylammonium/pharmacology , Vasodilator Agents/pharmacology , rho-Associated Kinases
9.
Pharmacol Biochem Behav ; 80(2): 289-96, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15680182

ABSTRACT

Intracerebroventricular (i.c.v.) injections of bombesin (BN) and gastrin-releasing peptide (GRP) dose-dependently decreased food intake in male Wistar rats fasted for 17 h. Neuromedin B (NMB) did not show any effect on food intake. After BN administration, locomotor activity did not significantly change, compared with a vehicle-injected group. The anorexia induced by BN (0.3 microg) was perfectly inhibited by pretreatment with a GRP-receptor antagonist, [D-Tyr(6)]BN(6-13) methyl ester (10 microg), an NO synthase inhibitor, L-nitro-arginine (30 microg), and a PKG inhibitor, H-9 (2 microg). The cGMP concentration in the hypothalamus increased 1 h after administration when compared with the vehicle-injected group. On the other hand, an NMB-receptor antagonist, BIM23127 (10 microg), and the protein kinase (PK) C inhibitors, chelerythrine (2 microg) and Go6983 (2 microg), inhibited only the late phase of the anorexia. A PKC activator, phorbol 12, 13-dibutyrate (3 microg), injected into the ventricle decreased food intake. These findings suggest that BN suppresses food intake mainly mediated through the GRP receptor and NO-cGMP-PKG pathway, and NMB receptor and PKC is partly involved in the late phase of the anorexia.


Subject(s)
Anorexia/chemically induced , Bombesin/administration & dosage , Lateral Ventricles/drug effects , Microinjections/methods , Telencephalon/drug effects , Animals , Eating/drug effects , Eating/physiology , Gastrin-Releasing Peptide/administration & dosage , Lateral Ventricles/physiology , Male , Motor Activity/drug effects , Motor Activity/physiology , Rats , Rats, Wistar , Telencephalon/physiology
10.
J Pharmacol Sci ; 95(4): 443-51, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15286430

ABSTRACT

We characterized the effects of vanadate, an inhibitor of tyrosine phosphatase, on the tension, the level of myosin light chain (MLC) phosphorylation, and Rho A activation in intact ileal longitudinal smooth muscle of the guinea pig to study the role of tyrosine phosphorylation in contraction signaling. Vanadate exerted a sustained contraction with a slow onset of tension development, in a concentration-dependent manner. The contractile effects of vanadate were accompanied by increases in the level of MLC phosphorylation. The tyrosine kinase inhibitor genistein; the MLC kinase inhibitor 1-(5-chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride (ML-9); and the Rho kinase inhibitor (+)-(R)-trans-4-(1-aminoethyl)-N-(4-pyridyl) cyclohexanecarboxamide dihydrochloride, monohydrate (Y-27632) inhibited the vanadate-induced contraction and MLC phosphorylation. Vanadate caused Rho A translocation from the cytosol to the membrane fraction, which was inhibited by genistein, but not by ML-9 and Y-27632. These data indicate that vanadate induces Rho A activation probably via protein tyrosine phosphorylation and the subsequent contraction through increases in the level of MLC phosphorylation.


Subject(s)
Ileum/drug effects , Muscle, Smooth/drug effects , Protein Tyrosine Phosphatases/antagonists & inhibitors , Vanadates/pharmacology , rhoA GTP-Binding Protein/metabolism , Animals , Dose-Response Relationship, Drug , Guinea Pigs , Ileum/physiology , In Vitro Techniques , Male , Muscle Contraction/drug effects , Muscle Contraction/physiology , Muscle, Smooth/physiology , Myosin Light Chains/metabolism , Phosphorylation , Protein Transport
11.
Brain Res ; 969(1-2): 88-94, 2003 Apr 18.
Article in English | MEDLINE | ID: mdl-12676368

ABSTRACT

Bombesin (BN) and structurally related peptides, gastrin-releasing peptide (GRP) and neuromedin B (NMB), injected into the lateral ventricle produce multiple effects such as hypothermia, anorexia and hormone release. In this study, the pharmacological characteristics of BN receptors mediating hypothermia in the central nervous system (CNS) were investigated using free-moving male Wistar rats. Intracerebroventricular injections of BN, GRP and NMB produced hypothermia in a dose-dependent manner. The BN (0.3 microg)-induced effect showed a short latency and a 4-h duration with a potency increased by more than 100 times compared to the NMB-induced effect. Pretreatment with [D-Tyr(6)]BN(6-13)methylester, a GRP receptor antagonist, inhibited the BN (0.3 microg)- and NMB (7 microg)-induced hypothermia. On the other hand, BIM23127, an NMB receptor antagonist, did not influence the hypothermia. Of the protein kinase C (PKC) inhibitors, chelerythrine, Go6983, staurosporine and GF109203X, the first two partially blocked the BN-induced hypothermia. A PKC activator, phorbol-12,13-dibutyrate, decreased the rectal temperature. Genistein (a tyrosine kinase inhibitor), Y-27632 (a Rho kinase inhibitor) and PD98059 (a MAPK inhibitor) tended to suppress the BN-induced hypothermia, however, these were not significant. The inhibitory effect of a mixture of the three inhibitors, chelerythrine, genistein and Y-27632, on the BN-induced hypothermia was of a similar degree to that of chelerythrine alone. The BN receptor mediating the hypothermia seem to be the GRP subtype, and the effect involves activation of PKC.


Subject(s)
Bombesin/analogs & derivatives , Bombesin/pharmacology , Brain/drug effects , Neurokinin B/analogs & derivatives , Protein Kinase C/metabolism , Receptors, Bombesin/metabolism , Signal Transduction/physiology , Animals , Body Temperature/drug effects , Bombesin/administration & dosage , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Gastrin-Releasing Peptide/administration & dosage , Gastrin-Releasing Peptide/pharmacology , Hypothermia/physiopathology , Injections, Intraventricular , Male , Neurokinin B/administration & dosage , Neurokinin B/pharmacology , Peptide Fragments/pharmacology , Protein Kinase C/antagonists & inhibitors , Rats , Rats, Wistar , Receptors, Bombesin/antagonists & inhibitors , Signal Transduction/drug effects
12.
Eur J Pharmacol ; 459(1): 65-73, 2003 Jan 10.
Article in English | MEDLINE | ID: mdl-12505535

ABSTRACT

The mechanisms underlying the hydrogen peroxide-induced relaxation of the norepinephrine-contraction were studied by measuring isometric force, myosin light chain (MLC(20)) phosphorylation and cyclic GMP in endothelium-denuded muscle from the guinea-pig aorta. Norepinephrine (5.2+/-1.3 microM) produced a phasic, followed by a tonic contraction. Hydrogen peroxide (10 and 100 microM), glyceryl trinitrate (30 and 300 nM) and 8-bromo cyclic GMP (30 and 100 microM) did not change the basal tone, but reduced the norepinephrine-induced contraction. Phosphorylation of MLC(20) (percentage of phosphorylated to total MLC(20)) was increased 1 min (5.9+/-1.0% vs. 35.9+/-4.9%) and, to a lesser extent, 20 min (3.7+/-1.7% vs. 13.9+/-1.6%) after the addition of norepinephrine. Hydrogen peroxide (100 microM) did not modify basal MLC(20) phosphorylation, but reduced the increase in MLC(20) phosphorylation induced by 1-min exposure to norepinephrine (20.9+/-4.1%). Its effect was abolished by catalase. When the tissue was incubated for 20 min with norepinephrine in the presence of hydrogen peroxide, norepinephrine-induced MLC(20) phosphorylation was not changed (13.6+/-1.5%), as compared to that in the absence of hydrogen peroxide. Hydrogen peroxide relaxed norepinephrine-stimulated aortas in a concentration-dependent fashion with EC(50) values of 5.9+/-0.2 microM. The relaxation was inhibited by soluble guanylate cyclase inhibitors and increased by an inhibitor of cyclic GMP-selective phosphodiesterase. In aorta precontracted with norepinephrine, hydrogen peroxide (100 microM) relaxed the tissue by 89+/-11% and almost doubled tissue concentrations of cyclic GMP, whereas sodium nitroprusside (1 microM) relaxed the tissue by 100% and increased cyclic GMP concentrations 30-fold. It is suggested that the inhibitory effects of hydrogen peroxide on the norepinephrine-induced phasic and sustained contractions are explained by a decrease in MLC(20) phosphorylation and by an alteration in MLC(20) phosphorylation-independent mechanisms, respectively. The effects of hydrogen peroxide were in part mediated by cyclic GMP.


Subject(s)
Aorta, Thoracic/drug effects , Cyclic GMP/analogs & derivatives , Endothelium, Vascular/physiology , Hydrogen Peroxide/pharmacology , Norepinephrine/pharmacology , Vasoconstriction/drug effects , Vasodilation/drug effects , Animals , Aorta, Thoracic/metabolism , Aorta, Thoracic/physiology , Cyclic GMP/metabolism , Cyclic GMP/pharmacology , Dose-Response Relationship, Drug , Guinea Pigs , In Vitro Techniques , Male , Methylene Blue/pharmacology , Myosin Light Chains/metabolism , Nitroglycerin/pharmacology , Oxadiazoles/pharmacology , Phosphorylation/drug effects , Purinones/pharmacology , Quinoxalines/pharmacology , Rats , Vasoconstrictor Agents/pharmacology , Vasodilator Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...